Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sabrina Strano

Showing results (51-60 of 112) with videos related to

Pageof 12
Sort By:
Omics : a Journal of Integrative Biology|February 26, 2011
Omics underpins novel clues on VDR chemoprevention target in breast cancerPaola Muti, Barbara Benassi, Elisabetta Falvo, et al.
Oncogene|July 12, 2005
deltaEF1 repressor controls selectively p53 family members during differentiationGiulia Fontemaggi, Aymone Gurtner, Alexander Damalas, et al.
Cell Cycle (Georgetown, Tex.)|July 3, 2008
Conditional RNA interference in vivo to study mutant p53 oncogenic gain of function on tumor malignancyGianluca Bossi, Francesco Marampon, Revital Maor-Aloni, et al.
Cell Cycle (Georgetown, Tex.)|October 25, 2008
The disruption of the protein complex mutantp53/p73 increases selectively the response of tumor cells to anticancer drugsSilvia Di Agostino, Giancarlo Cortese, Olimpia Monti, et al.
Cell Death Discovery|October 25, 2024
The oncogenic axis YAP/MYC/EZH2 impairs PTEN tumor suppression activity enhancing lung tumorigenicityFederica Lo Sardo, Chiara Turco, Beatrice Messina, et al.
Omics : a Journal of Integrative Biology|February 22, 2011
ChIP-on-chip analysis of in vivo mutant p53 binding to selected gene promotersStefania Dell'Orso, Giulia Fontemaggi, Perry Stambolsky, et al.
Cell Death & Disease|August 20, 2024
Targeting of mutant-p53 and MYC as a novel strategy to inhibit oncogenic SPAG5 activity in triple negative breast cancerValeria Canu, Sebastiano Vaccarella, Andrea Sacconi, et al.
Blood Cells, Molecules & Diseases|February 9, 2016
Sibling cord blood donor program for hematopoietic cell transplantation: the 20-year experience in the Rome Cord Blood BankMaria Screnci, Emilia Murgi, Veronica Valle, et al.
Omics : a Journal of Integrative Biology|February 26, 2011
Allelic expression imbalance of TP53 mutated and polymorphic alleles in head and neck tumorsFederica Ganci, Salvatore Conti, Giulia Fontemaggi, et al.
Theranostics|March 21, 2018
Long Non-coding MIR205HG Depletes Hsa-miR-590-3p Leading to Unrestrained Proliferation in Head and Neck Squamous Cell CarcinomaSilvia Di Agostino, Fabio Valenti, Andrea Sacconi, et al.
Pageof 12

Showing results (51-60 of 112) with videos related to

Sort By:
Pageof 12
Omics : a Journal of Integrative Biology|February 26, 2011
Omics underpins novel clues on VDR chemoprevention target in breast cancerPaola Muti, Barbara Benassi, Elisabetta Falvo, et al.
Oncogene|July 12, 2005
deltaEF1 repressor controls selectively p53 family members during differentiationGiulia Fontemaggi, Aymone Gurtner, Alexander Damalas, et al.
Cell Cycle (Georgetown, Tex.)|July 3, 2008
Conditional RNA interference in vivo to study mutant p53 oncogenic gain of function on tumor malignancyGianluca Bossi, Francesco Marampon, Revital Maor-Aloni, et al.
Cell Cycle (Georgetown, Tex.)|October 25, 2008
The disruption of the protein complex mutantp53/p73 increases selectively the response of tumor cells to anticancer drugsSilvia Di Agostino, Giancarlo Cortese, Olimpia Monti, et al.
Cell Death Discovery|October 25, 2024
The oncogenic axis YAP/MYC/EZH2 impairs PTEN tumor suppression activity enhancing lung tumorigenicityFederica Lo Sardo, Chiara Turco, Beatrice Messina, et al.
Omics : a Journal of Integrative Biology|February 22, 2011
ChIP-on-chip analysis of in vivo mutant p53 binding to selected gene promotersStefania Dell'Orso, Giulia Fontemaggi, Perry Stambolsky, et al.
Cell Death & Disease|August 20, 2024
Targeting of mutant-p53 and MYC as a novel strategy to inhibit oncogenic SPAG5 activity in triple negative breast cancerValeria Canu, Sebastiano Vaccarella, Andrea Sacconi, et al.
Blood Cells, Molecules & Diseases|February 9, 2016
Sibling cord blood donor program for hematopoietic cell transplantation: the 20-year experience in the Rome Cord Blood BankMaria Screnci, Emilia Murgi, Veronica Valle, et al.
Omics : a Journal of Integrative Biology|February 26, 2011
Allelic expression imbalance of TP53 mutated and polymorphic alleles in head and neck tumorsFederica Ganci, Salvatore Conti, Giulia Fontemaggi, et al.
Theranostics|March 21, 2018
Long Non-coding MIR205HG Depletes Hsa-miR-590-3p Leading to Unrestrained Proliferation in Head and Neck Squamous Cell CarcinomaSilvia Di Agostino, Fabio Valenti, Andrea Sacconi, et al.
Pageof 12